Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC)
Shenjia Wu, Ying Guo, Rong Wang. Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC). // BMC Cancer. – 2025. – DOI: 10.1186/s12885-025-14066-3. – URL: https://doi.org/10.1186/s12885-025-14066-3
Shenjia Wu, Ying Guo, & Rong Wang (2025). Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC). BMC Cancer. https://doi.org/10.1186/s12885-025-14066-3
Shenjia Wu, et al. “Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC).” BMC Cancer, 2025. doi:10.1186/s12885-025-14066-3.
@article{Wu2025,
title = {Combining network pharmacology and experimental verification to explore the inhibitory effects of Deoxyelephantopin (DET) Against Non-Small Cell Lung Cancer (NSCLC)},
author = {Wu, Shenjia and Guo, Ying and Wang, Rong},
journal = {BMC Cancer},
year = {2025},
doi = {10.1186/s12885-025-14066-3},
url = {https://doi.org/10.1186/s12885-025-14066-3}
}